Another gene therapy setback as biotech halts 200-job Durham facility


One of the Triangle's recent economic development wins in the life sciences industry appears unlikely to ever reach fruition.

Previous Harvard Pilgrim's parent mum on timeline to fix cybersecurity hack
Next Here are the startups competing at e-Fest, the University of St. Thomas startup competition